Anxo Pharmaceutical Co., Ltd. (TPEX:6677)
Taiwan
· Delayed Price · Currency is TWD 20.05
-0.15 (-0.74%)
At close: Mar 9, 2026
Anxo Pharmaceutical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 1,120 | 1,336 | 2,708 | 1,426 | 1,185 | 1,376 | Upgrade
|
| Market Cap Growth | -18.41% | -50.67% | 89.95% | 20.32% | -13.90% | -3.90% | Upgrade
|
| Enterprise Value | 1,641 | 1,837 | 3,497 | 2,194 | 1,989 | 2,164 | Upgrade
|
| Last Close Price | 20.05 | 24.00 | 48.11 | 28.23 | 23.46 | 27.25 | Upgrade
|
| PE Ratio | - | - | 123.88 | - | 61.60 | 43.82 | Upgrade
|
| PS Ratio | 1.27 | 1.49 | 2.88 | 1.65 | 1.44 | 1.59 | Upgrade
|
| PB Ratio | 1.00 | 1.17 | 2.25 | 1.72 | 1.42 | 1.70 | Upgrade
|
| P/TBV Ratio | 1.17 | 1.37 | 2.58 | 2.09 | 1.71 | 2.05 | Upgrade
|
| P/FCF Ratio | 39.05 | 19.18 | - | 25.16 | 27.23 | 31.35 | Upgrade
|
| P/OCF Ratio | 17.01 | 11.93 | - | 20.00 | 15.12 | 22.98 | Upgrade
|
| EV/Sales Ratio | 1.86 | 2.05 | 3.72 | 2.53 | 2.41 | 2.50 | Upgrade
|
| EV/EBITDA Ratio | 60.52 | 448.02 | 30.92 | 32.01 | 19.10 | 17.14 | Upgrade
|
| EV/EBIT Ratio | - | - | 65.59 | 368.98 | 49.61 | 37.97 | Upgrade
|
| EV/FCF Ratio | 57.21 | 26.38 | - | 38.71 | 45.73 | 49.29 | Upgrade
|
| Debt / Equity Ratio | 0.64 | 0.64 | 0.66 | 1.07 | 1.06 | 1.10 | Upgrade
|
| Debt / EBITDA Ratio | 26.51 | 38.13 | 6.21 | 11.18 | 7.74 | 6.52 | Upgrade
|
| Debt / FCF Ratio | 25.06 | 10.44 | - | 15.65 | 20.28 | 20.25 | Upgrade
|
| Net Debt / Equity Ratio | 0.36 | 0.32 | 0.34 | 0.78 | 0.80 | 0.84 | Upgrade
|
| Net Debt / EBITDA Ratio | 32.50 | 89.14 | 3.56 | 9.42 | 6.42 | 5.40 | Upgrade
|
| Net Debt / FCF Ratio | 14.10 | 5.25 | -6.66 | 11.39 | 15.36 | 15.52 | Upgrade
|
| Asset Turnover | 0.42 | 0.41 | 0.45 | 0.45 | 0.43 | 0.45 | Upgrade
|
| Inventory Turnover | 2.02 | 2.09 | 2.06 | 2.22 | 1.95 | 2.13 | Upgrade
|
| Quick Ratio | 1.06 | 1.15 | 1.33 | 0.89 | 0.92 | 0.88 | Upgrade
|
| Current Ratio | 1.68 | 1.75 | 2.01 | 1.39 | 1.49 | 1.51 | Upgrade
|
| Return on Equity (ROE) | -3.79% | -4.62% | 3.03% | -0.85% | 2.40% | 5.15% | Upgrade
|
| Return on Assets (ROA) | -1.42% | -1.64% | 1.59% | 0.19% | 1.31% | 1.86% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.15% | -3.64% | 2.76% | 0.40% | 2.17% | 3.01% | Upgrade
|
| Return on Capital Employed (ROCE) | -3.10% | -3.50% | 3.10% | 0.40% | 2.80% | 3.90% | Upgrade
|
| Earnings Yield | -3.78% | -4.28% | 0.81% | -0.88% | 1.62% | 2.28% | Upgrade
|
| FCF Yield | 2.56% | 5.21% | -2.23% | 3.98% | 3.67% | 3.19% | Upgrade
|
| Dividend Yield | - | - | 0.83% | - | - | - | Upgrade
|
| Payout Ratio | - | - | - | - | - | 36.52% | Upgrade
|
| Buyback Yield / Dilution | -2.25% | -8.00% | -7.11% | 0.66% | -0.88% | -7.05% | Upgrade
|
| Total Shareholder Return | -2.25% | -8.00% | -6.28% | 0.66% | -0.88% | -7.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.